Skip to content

Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology

Clinician Nudge to Referral of Adnexal Masses to Gynecologic Oncology

Status
Enrolling by invitation
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07078409
Enrollment
240
Registered
2025-07-22
Start date
2025-07-14
Completion date
2028-07-07
Last updated
2026-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ovarian Cancer

Keywords

nudge

Brief summary

The goal of this study is to test the effectiveness of clinician nudges on referrals to gynecologic oncology in patients with suspected ovarian cancer. The primary outcome will be whether or not patients were referred to gynecologic oncology within 14 days of their abnormal imaging results. Secondary and exploratory outcomes are whether the gynecologic visit occurred within 60 days of abnormal imaging and the time from abnormal imaging results to gynecologic oncology visit.

Interventions

BEHAVIORALNudge

When the clinician who ordered the imaging that led to randomization receives the test results, a pre-checked referral order to gynecologic oncology for surgical evaluation will appear in the EHR alongside a brief educational explanation. This will constitute the opt-out default referral order (Figure 3). Clinicians will have the option to unclick the referral to opt out and will be asked to indicate the reason from a pre-populated list of choices; if they do not opt out, the referral to gynecologic oncology will proceed. Imaging findings and referral will be communicated to the patient in keeping with the clinician's usual practice. In keeping with routine practice, referred patients will be contacted by gynecologic oncology's new patient coordinators within 72 hours and offered an appointment within 2 weeks at their preferred location.

Sponsors

Abramson Cancer Center at Penn Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Eligible clinicians include physicians, physician assistants, and nurse practitioners with eligible patient encounters at sites included in the trial during the study. * Eligible patient encounters are defined as an emergency room visit, inpatient hospitalization, or outpatient visit during the study period where the patient had associated imaging with suspected ovarian cancer (O-RADS 4 or 5 lesion), identified with the EHR-based tool described above.

Exclusion criteria

* Known diagnosis of ovarian cancer. * Imaging ordered by gynecologic oncologist.

Design outcomes

Primary

MeasureTime frameDescription
Referral RateUp to one yearBinary indicator of whether the patient was referred to gynecologic oncology within 14 days of abnormal imaging results.

Secondary

MeasureTime frameDescription
Gynecologic Oncology VisitUp to one yearWhether or not the gynecologic oncology visit occurred within 60 days of abnormal imaging.
Time from imaging to visitUp to one yearTime from abnormal imaging results to gynecologic oncology visit.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 28, 2026